Nkarta, Inc.
Clinical trials sponsored by Nkarta, Inc., explained in plain language.
-
Immune cell therapy takes on lupus kidney disease
Disease control Recruiting nowThis study tests a new treatment called NKX019, which uses specially engineered immune cells (CAR NK cells) to target and calm overactive immune cells that attack the kidneys. It is for people with active lupus nephritis or primary membranous nephropathy who have not responded to…
Phase: PHASE1, PHASE2 • Sponsor: Nkarta, Inc. • Aim: Disease control
Last updated May 17, 2026 03:14 UTC
-
Could immune cells tame autoimmune diseases?
Disease control Recruiting nowThis study tests a new treatment called NKX019, made from donor immune cells engineered to target and calm overactive immune cells. It is for people with certain autoimmune diseases like systemic sclerosis, inflammatory myopathies, or vasculitis. The goal is to see if it is safe …
Phase: PHASE1, PHASE2 • Sponsor: Nkarta, Inc. • Aim: Disease control
Last updated May 05, 2026 11:54 UTC